Next Quarterly Earnings
Monday, August 17, 2026
CW 34
Pre-Market
In 43 days
GeneDx Holdings
GeneDx Holdings is a leading US-based genomic diagnostics company. It offers specialized genetic testing for rare and neurological diseases. Through advanced genome sequencing, GeneDx enables precise diagnoses and innovative precision medicine solutions, significantly improving patient care within healthcare.
All Dates
Earnings history data not available
Company Information
Name
GeneDx Holdings
Country
🇺🇸
More Financial Information